Abstract
Loss of sexual desire is a common problem among surgically menopausal women that often results in personal distress and diminished quality of life. Various physiological, psychosocial, and interpersonal factors may contribute, but the hormonal changes induced by the removal of the ovaries should not be overlooked. Postoperative declines in testosterone often result in loss of sexual desire, and estrogen deficiency may aggravate the situation, leading to vaginal atrophy, dryness, and pain during intercourse. Physicians direct questioning about sexual function is an essential step in establishing a dialogue before and after surgery. When complaints of low sexual desire are present, a thorough sexual, medical, and psychosocial history is needed to help delineate underlying causes and establish a diagnosis. Hypoactive sexual desire disorder (HSDD) may be diagnosed in women with a persistent lack of interest in, desire for, or receptivity to sexual activity that causes personal distress. An integrated treatment approach may be most successful. Recent evidence suggests that testosterone therapy is effective in restoring sexual desire in surgically menopausal women with HSDD. Additional clinical trials are needed to define the efficacy and tolerability of the different testosterone therapies and establish long-term safety, ensuring appropriate use in clinical practice.
Keywords: sexual dysfunction, low sexual desire, postmenopausal women, testosterone therapy
Call for Papers in Thematic Issues
RARE CASES IN GYNECOLOGY-OBSTETRICS
With the development of diagnostic and therapeutic techniques (such as ART techniques) and the immersion of new pathologies (such as COVID19), we are witnessing an increase in the incidence of pathologies that were previously described as rare or exceptional. the practitioner sometimes confronts difficult situations in these cases in diagnostic ...read more
4